• AgPlenus, an Evogene subsidiary, launched an Antifungal Potency Predictor AI model to rank antifungal small molecules from chemical structure.
• The model expands ChemPass AI for Ag by forecasting biological efficacy before synthesis or fungal assays, aiming to cut early-stage testing.
• AgPlenus expects the tool to support its fungicide pipeline, including APTF-1, amid rising resistance and a fungicide market estimated at about USD 22 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evogene Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: IO05149) on July 15, 2026, and is solely responsible for the information contained therein.